ANIP
Price
$98.84
Change
+$1.13 (+1.16%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
2.12B
51 days until earnings call
PRGO
Price
$21.75
Change
-$0.52 (-2.33%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
3.06B
51 days until earnings call
Interact to see
Advertisement

ANIP vs PRGO

Header iconANIP vs PRGO Comparison
Open Charts ANIP vs PRGOBanner chart's image
ANI Pharmaceuticals
Price$98.84
Change+$1.13 (+1.16%)
Volume$6.73K
Capitalization2.12B
Perrigo
Price$21.75
Change-$0.52 (-2.33%)
Volume$26.47K
Capitalization3.06B
ANIP vs PRGO Comparison Chart in %
Loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIP vs. PRGO commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a Hold and PRGO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (ANIP: $97.71 vs. PRGO: $22.27)
Brand notoriety: ANIP and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ANIP: 40% vs. PRGO: 87%
Market capitalization -- ANIP: $2.12B vs. PRGO: $3.06B
ANIP [@Pharmaceuticals: Generic] is valued at $2.12B. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $3.06B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.68B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 1 FA rating(s) are green whilePRGO’s FA Score has 2 green FA rating(s).

  • ANIP’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 2 green, 3 red.
According to our system of comparison, both ANIP and PRGO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 3 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • ANIP’s TA Score: 3 bullish, 5 bearish.
  • PRGO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than ANIP.

Price Growth

ANIP (@Pharmaceuticals: Generic) experienced а +2.48% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was -1.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.21%. For the same industry, the average monthly price growth was +6.07%, and the average quarterly price growth was +39.76%.

Reported Earning Dates

ANIP is expected to report earnings on Nov 05, 2025.

PRGO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.21% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRGO($3.06B) has a higher market cap than ANIP($2.12B). PRGO has higher P/E ratio than ANIP: PRGO (2818.00) vs ANIP (51.82). ANIP YTD gains are higher at: 76.755 vs. PRGO (-10.457). PRGO has higher annual earnings (EBITDA): 612M vs. ANIP (89M). PRGO has more cash in the bank: 454M vs. ANIP (224M). ANIP has less debt than PRGO: ANIP (622M) vs PRGO (3.65B). PRGO has higher revenues than ANIP: PRGO (4.33B) vs ANIP (747M).
ANIPPRGOANIP / PRGO
Capitalization2.12B3.06B69%
EBITDA89M612M15%
Gain YTD76.755-10.457-734%
P/E Ratio51.822818.002%
Revenue747M4.33B17%
Total Cash224M454M49%
Total Debt622M3.65B17%
FUNDAMENTALS RATINGS
ANIP vs PRGO: Fundamental Ratings
ANIP
PRGO
OUTLOOK RATING
1..100
4057
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
32
Undervalued
PROFIT vs RISK RATING
1..100
23100
SMR RATING
1..100
9392
PRICE GROWTH RATING
1..100
3882
P/E GROWTH RATING
1..100
932
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (32) in the Pharmaceuticals Other industry is somewhat better than the same rating for ANIP (94). This means that PRGO’s stock grew somewhat faster than ANIP’s over the last 12 months.

ANIP's Profit vs Risk Rating (23) in the Pharmaceuticals Other industry is significantly better than the same rating for PRGO (100). This means that ANIP’s stock grew significantly faster than PRGO’s over the last 12 months.

PRGO's SMR Rating (92) in the Pharmaceuticals Other industry is in the same range as ANIP (93). This means that PRGO’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's Price Growth Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for PRGO (82). This means that ANIP’s stock grew somewhat faster than PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for ANIP (93). This means that PRGO’s stock grew significantly faster than ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPPRGO
RSI
ODDS (%)
Bearish Trend 6 days ago
67%
Bullish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
76%
Bullish Trend 4 days ago
76%
Momentum
ODDS (%)
Bullish Trend 8 days ago
81%
Bearish Trend 4 days ago
59%
MACD
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
61%
Advances
ODDS (%)
Bullish Trend 12 days ago
74%
Bullish Trend 27 days ago
61%
Declines
ODDS (%)
Bearish Trend 8 days ago
68%
Bearish Trend 6 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
57%
Aroon
ODDS (%)
Bullish Trend 4 days ago
73%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEOSX16.780.06
+0.36%
Voya Large Cap Growth Port S
MLRTX10.56N/A
N/A
NYLI Winslow Large Cap Growth Class R2
ACEAX10.89-0.02
-0.18%
AB All China Equity A
FNGZX18.39-0.05
-0.27%
Franklin Intl Growth Adv
PJGZX23.76-0.07
-0.29%
PGIM Jennison Focused Value Z

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with ORGO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-1.24%
ORGO - PRGO
46%
Loosely correlated
-2.18%
EOLS - PRGO
43%
Loosely correlated
-4.26%
AMRX - PRGO
38%
Loosely correlated
-0.89%
PBH - PRGO
35%
Loosely correlated
-2.72%
ZTS - PRGO
32%
Poorly correlated
-1.60%
More